Novel combination strategy to optimize treatment for PTSD

Mujeeb U. Shad, Alina M. Suris, Carol S. North

    Research output: Contribution to journalReview article

    21 Scopus citations

    Abstract

    Post-traumatic stress disorder (PTSD) is increasingly recognized as a serious and potentially debilitating condition in combat veterans returning from Iraq and Afghanistan. Exposure to a potentially life-threatening event such as military combat may be followed by PTSD. Despite recent advances in pharmacotherapy for PTSD, monotherapy with the currently available medications is only partially effective, as demonstrated in large clinical trials of combat veterans with PTSD. This underscores the need to investigate novel combination strategies to enhance treatment response in PTSD. The α-1 adrenergic receptor (AR) antagonist, prazosin, appears promising in recent studies for its capacity to reduce trauma-related nightmares (a group B night-time intrusion symptom) and insomnia (a group D night-time arousal symptom), while recent evidence supports using the β-AR antagonist, propranolol, to dampen the emotional content of traumatic memories (daytime intrusion symptoms including flashbacks, intrusive recollections of traumatic event, and heightened physiological reactivity/responsivity to trauma reminders). In this review, we present data supporting the potential utility of combined drug regimen (prazosin and propranolol) acting through different noradrenergic mechanisms, with the potential to target more than one set of PTSD symptoms to optimize PTSD treatment.

    Original languageEnglish (US)
    Pages (from-to)4-11
    Number of pages8
    JournalHuman Psychopharmacology
    Volume26
    Issue number1
    DOIs
    StatePublished - Jan 1 2011

    Keywords

    • Combination
    • Novel
    • PTSD
    • Treatment

    ASJC Scopus subject areas

    • Neurology
    • Clinical Neurology
    • Psychiatry and Mental health
    • Pharmacology (medical)

    Fingerprint Dive into the research topics of 'Novel combination strategy to optimize treatment for PTSD'. Together they form a unique fingerprint.

  • Cite this